Cargando…

Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Different Metabolic Phenotypes

BACKGROUND: The positive relationship between metabolic healthy obesity (MHO) and cardiovascular risk has been under debate in recent years. Previously, strong evidence supported the causal role of increased plasma lipoprotein(a) [Lp(a)] levels in cardiovascular disease (CVD). The current study aime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Jing-Lu, Zhang, Hui-Wen, Liu, Hui-Hui, Zhu, Cheng-Gang, Guo, Yuan-Lin, Wu, Na-Qiong, Xu, Rui-Xia, Dong, Qian, Li, Jian-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163309/ https://www.ncbi.nlm.nih.gov/pubmed/35669468 http://dx.doi.org/10.3389/fcvm.2022.870341

Ejemplares similares

Comparison of Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement and Lipid-Lowering Therapy in the Patients With Coronary Artery Disease With Different Renal Functions
por: Zhang, Shuang, et al.
Publicado: (2022)

Serum fibrinogen and cardiovascular events in Chinese patients with type 2 diabetes and stable coronary artery disease: a prospective observational study
por: Yang, Sheng-Hua, et al.
Publicado: (2017)

Relationship between the neutrophil to high-density lipoprotein cholesterol ratio and severity of coronary artery disease in patients with stable coronary artery disease
por: Gao, Jie, et al.
Publicado: (2022)

CYP2C19 metabolizer phenotypes may affect the efficacy of statins on lowering small dense low-density lipoprotein cholesterol of patients with coronary artery disease
por: Dai, Ruozhu, et al.
Publicado: (2022)

Cardiovascular Phenotypes Profiling for L-Transposition of the Great Arteries and Prognosis Analysis
por: He, Qiyu, et al.
Publicado: (2022)

Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis
por: Luo, Jin-Wen, et al.
Publicado: (2021)

Low-Density Lipoprotein Cholesterol 4: The Notable Risk Factor of Coronary Artery Disease Development
por: Wu, Dongmei, et al.
Publicado: (2021)

Phenotypic Clustering of Patients With Newly Diagnosed Coronary Artery Disease Using Cardiovascular Magnetic Resonance and Coronary Computed Tomography Angiography
por: Pezel, Théo, et al.
Publicado: (2021)

Impact of low-density lipoprotein cholesterol and lipoprotein(a) on mid-term clinical outcomes following coronary artery bypass grafting: A secondary analysis of the DACAB trial
por: Yu, Qixiang, et al.
Publicado: (2023)

Impact of Conventional Cardiovascular Risk Factors on Left Internal Mammary Artery Graft Disease
por: Zuo, Hui-Juan, et al.
Publicado: (2022)

Baseline Low-Density-Lipoprotein Cholesterol Modifies the Risk of All-Cause Death Associated With Elevated Lipoprotein(a) in Coronary Artery Disease Patients
por: Yao, Younan, et al.
Publicado: (2022)

Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins
por: Wang, Le, et al.
Publicado: (2021)

Associations of Lipoprotein(a) With Coronary Atherosclerotic Burden and All-Cause Mortality in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
por: Xue, Yuzhou, et al.
Publicado: (2021)

Association of small dense low-density lipoprotein with cardiovascular outcome in patients with coronary artery disease and diabetes: a prospective, observational cohort study
por: Jin, Jing-Lu, et al.
Publicado: (2020)

Pre-operative evaluation and mid-term outcomes of anomalous origin of the left coronary artery from the pulmonary artery based on left ventricular ejection fraction
por: Xia, Shu-Liang, et al.
Publicado: (2022)

Coronary artery calcium scoring as a tool for risk stratification in patients with an elevated lipoprotein(a) level
por: Naami, Robert, et al.
Publicado: (2022)

Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges
por: Tintut, Yin, et al.
Publicado: (2018)

Low Molecular Weight Apolipoprotein(a) Phenotype Rather Than Lipoprotein(a) Is Associated With Coronary Atherosclerosis and Myocardial Infarction
por: Afanasieva, Olga I., et al.
Publicado: (2022)

A Phenotype and Genotype Case Report of a Neonate With Congenital Bilateral Coronary Artery Fistulas and Multiple Collateral Arteries
por: Su, Shixin, et al.
Publicado: (2022)

Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans
por: Ferrannini, Ele, et al.
Publicado: (2022)

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity C-Reactive Protein in Patients With Previous Myocardial Infarction
por: Cao, Ye-Xuan, et al.
Publicado: (2022)

Risk factors for major adverse cardiovascular events after coronary artery bypass grafting using radial artery grafts
por: Xia, Tianyu, et al.
Publicado: (2023)

The impact of circulating IGF-1 and IGFBP-2 on cardiovascular prognosis in patients with acute coronary syndrome
por: Wang, Wei, et al.
Publicado: (2023)

Levels of Lipoprotein (a) in patients with coronary artery disease with and without inflammatory rheumatic disease: a cross-sectional study
por: Holm, Sverre, et al.
Publicado: (2019)

Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients
por: Liu, Jin, et al.
Publicado: (2021)

ANGPTL3 Is Involved in the Post-prandial Response in Triglyceride-Rich Lipoproteins and HDL Components in Patients With Coronary Artery Disease
por: Guo, Xin, et al.
Publicado: (2022)

Identification of Specific Coronary Artery Disease Phenotypes Implicating Differential Pathophysiologies
por: Krohn, Jona B., et al.
Publicado: (2022)

Editorial: Metabolism Linking Immunity and Inflammatory Phenotypes in Cardiovascular Disease
por: Vijayan, Murali, et al.
Publicado: (2022)

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

ALB-dNLR Score Predicts Mortality in Coronary Artery Disease Patients After Percutaneous Coronary Intervention
por: Xiu, Wen-Juan, et al.
Publicado: (2022)

Sleep Quality, Sleep Duration, and the Risk of Adverse Clinical Outcomes in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries
por: Zhu, Chun-Yan, et al.
Publicado: (2022)

Adjustment of the GRACE Risk Score by Monocyte to High-Density Lipoprotein Ratio Improves Prediction of Adverse Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Ma, Xiaoteng, et al.
Publicado: (2022)

Association Between Circulating Retinol-Binding Protein 4 and Adverse Cardiovascular Events in Stable Coronary Artery Disease
por: Qian, Ke, et al.
Publicado: (2022)

Lesion Length Improves Diagnostic Accuracy of Intravascular Ultrasound for Detecting Functional Intermediate Coronary Stenosis Evaluated With Coronary Angiography-Derived Fractional Flow Reserve in Non-left Main Artery
por: Li, Menghuan, et al.
Publicado: (2021)

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis
por: Chew, Nicholas W. S., et al.
Publicado: (2022)

Association Between Obstructive Sleep Apnea-Hypopnea Syndrome and Outcomes in Patients With Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease
por: He, Chao-Jie, et al.
Publicado: (2020)

Three polymethoxyflavones from the peel of Citrus reticulata “Chachi” inhibits oxidized low-density lipoprotein-induced macrophage-derived foam cell formation
por: Liang, Pu-Lin, et al.
Publicado: (2022)

Coronary Artery Calcification Under Statin Therapy and Its Effect on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Lai, Runmin, et al.
Publicado: (2020)

Symptomatic intracerebral hemorrhage after non-emergency percutaneous coronary intervention: Incidence, risk factors, and association with cardiovascular outcomes
por: Lim, Mervyn Jun Rui, et al.
Publicado: (2022)

Cohort profile: role of lipoproteins in cardiovascular disease—the LipidCardio study
por: König, Maximilian, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_spiu0tn867hfm50sf9cks7h69a